- $89.13m
- -$77.83m
- CNY1.02bn
- 93
- 99
- 35
- 89
Annual balance sheet for Ihuman, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS | 20-F | 20-F | 20-F | 20-F |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 105 | 862 | 855 | 1,050 | 1,214 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 21 | 78.3 | 59 | 81.9 | 62.6 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 163 | 1,021 | 1,015 | 1,254 | 1,382 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 2.49 | 12.9 | 50.5 | 22 | 9.82 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 168 | 1,047 | 1,101 | 1,333 | 1,450 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 183 | 399 | 483 | 561 | 491 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 183 | 404 | 493 | 564 | 493 |
Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | -14.4 | 643 | 608 | 769 | 958 |
Total Liabilities & Shareholders' Equity | 168 | 1,047 | 1,101 | 1,333 | 1,450 |
Total Common Shares Outstanding |